697 related articles for article (PubMed ID: 21454665)
1. SYT-SSX1 (synovial sarcoma translocated) regulates PIASy ligase activity to cause overexpression of NCOA3 protein.
Sun Y; Perera J; Rubin BP; Huang J
J Biol Chem; 2011 May; 286(21):18623-32. PubMed ID: 21454665
[TBL] [Abstract][Full Text] [Related]
2. IGF2 is critical for tumorigenesis by synovial sarcoma oncoprotein SYT-SSX1.
Sun Y; Gao D; Liu Y; Huang J; Lessnick S; Tanaka S
Oncogene; 2006 Feb; 25(7):1042-52. PubMed ID: 16247461
[TBL] [Abstract][Full Text] [Related]
3. SYT-SSX1 and SYT-SSX2 interfere with repression of E-cadherin by snail and slug: a potential mechanism for aberrant mesenchymal to epithelial transition in human synovial sarcoma.
Saito T; Nagai M; Ladanyi M
Cancer Res; 2006 Jul; 66(14):6919-27. PubMed ID: 16849535
[TBL] [Abstract][Full Text] [Related]
4. Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/neu in synovial sarcoma.
Thomas DG; Giordano TJ; Sanders D; Biermann S; Sondak VK; Trent JC; Yu D; Pollock RE; Baker L
Cancer; 2005 Feb; 103(4):830-8. PubMed ID: 15641030
[TBL] [Abstract][Full Text] [Related]
5. The SYT-SSX fusion protein down-regulates the cell proliferation regulator COM1 in t(x;18) synovial sarcoma.
Ishida M; Miyamoto M; Naitoh S; Tatsuda D; Hasegawa T; Nemoto T; Yokozeki H; Nishioka K; Matsukage A; Ohki M; Ohta T
Mol Cell Biol; 2007 Feb; 27(4):1348-55. PubMed ID: 17101797
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of molecular and cytogenetic findings in synovial sarcoma.
Panagopoulos I; Mertens F; Isaksson M; Limon J; Gustafson P; Skytting B; Akerman M; Sciot R; Dal Cin P; Samson I; Iliszko M; Ryoe J; Dêbiec-Rychter M; Szadowska A; Brosjö O; Larsson O; Rydholm A; Mandahl N
Genes Chromosomes Cancer; 2001 Aug; 31(4):362-72. PubMed ID: 11433527
[TBL] [Abstract][Full Text] [Related]
7. Co-existence of SYT-SSX1 and SYT-SSX2 fusions in synovial sarcomas.
Yang K; Lui WO; Xie Y; Zhang A; Skytting B; Mandahl N; Larsson C; Larsson O
Oncogene; 2002 Jun; 21(26):4181-90. PubMed ID: 12037676
[TBL] [Abstract][Full Text] [Related]
8. Real-time polymerase chain reaction as an aid for the detection of SYT-SSX1 and SYT-SSX2 transcripts in fresh and archival pediatric synovial sarcoma specimens: report of 25 cases from St. Jude Children's Research Hospital.
Hill DA; Riedley SE; Patel AR; Shurtleff SA; Hyer J; Cain AM; Billups CA; Downing JR; Pappo AS
Pediatr Dev Pathol; 2003; 6(1):24-34. PubMed ID: 12469233
[TBL] [Abstract][Full Text] [Related]
9. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma.
Kawai A; Woodruff J; Healey JH; Brennan MF; Antonescu CR; Ladanyi M
N Engl J Med; 1998 Jan; 338(3):153-60. PubMed ID: 9428816
[TBL] [Abstract][Full Text] [Related]
10. Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma.
Antonescu CR; Kawai A; Leung DH; Lonardo F; Woodruff JM; Healey JH; Ladanyi M
Diagn Mol Pathol; 2000 Mar; 9(1):1-8. PubMed ID: 10718206
[TBL] [Abstract][Full Text] [Related]
11. The synovial sarcoma translocation protein SYT-SSX2 recruits beta-catenin to the nucleus and associates with it in an active complex.
Pretto D; Barco R; Rivera J; Neel N; Gustavson MD; Eid JE
Oncogene; 2006 Jun; 25(26):3661-9. PubMed ID: 16462762
[TBL] [Abstract][Full Text] [Related]
12. The SYT-SSX fusion protein and histological epithelial differentiation in synovial sarcoma: relationship with extracellular matrix remodeling.
Saito T
Int J Clin Exp Pathol; 2013; 6(11):2272-9. PubMed ID: 24228088
[TBL] [Abstract][Full Text] [Related]
13. SUMO-1 modification of PIASy, an E3 ligase, is necessary for PIASy-dependent activation of Tcf-4.
Ihara M; Yamamoto H; Kikuchi A
Mol Cell Biol; 2005 May; 25(9):3506-18. PubMed ID: 15831457
[TBL] [Abstract][Full Text] [Related]
14. Analysis of transforming activity of human synovial sarcoma-associated chimeric protein SYT-SSX1 bound to chromatin remodeling factor hBRM/hSNF2 alpha.
Nagai M; Tanaka S; Tsuda M; Endo S; Kato H; Sonobe H; Minami A; Hiraga H; Nishihara H; Sawa H; Nagashima K
Proc Natl Acad Sci U S A; 2001 Mar; 98(7):3843-8. PubMed ID: 11274403
[TBL] [Abstract][Full Text] [Related]
15. SYT-SSX1 enhances the invasiveness and maintains stem-like cell properties in synovial sarcoma via induction of TGF-β1/Smad signaling.
Qi Y; Dong SS; He YL; Liu ZH; Huang YL; Wang N; Zhang Z; Li Z; Shi METHTM; Feng X; Yao Q; Zou H; Hu JM; Pang LJ; Li F
BMC Cancer; 2022 Feb; 22(1):166. PubMed ID: 35151264
[TBL] [Abstract][Full Text] [Related]
16. Fusions of the SYT and SSX genes in synovial sarcoma.
Ladanyi M
Oncogene; 2001 Sep; 20(40):5755-62. PubMed ID: 11607825
[TBL] [Abstract][Full Text] [Related]
17. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.
Ladanyi M; Antonescu CR; Leung DH; Woodruff JM; Kawai A; Healey JH; Brennan MF; Bridge JA; Neff JR; Barr FG; Goldsmith JD; Brooks JS; Goldblum JR; Ali SZ; Shipley J; Cooper CS; Fisher C; Skytting B; Larsson O
Cancer Res; 2002 Jan; 62(1):135-40. PubMed ID: 11782370
[TBL] [Abstract][Full Text] [Related]
18. Nuclear localization of SYT, SSX and the synovial sarcoma-associated SYT-SSX fusion proteins.
dos Santos NR; de Bruijn DR; Balemans M; Janssen B; Gärtner F; Lopes JM; de Leeuw B; Geurts van Kessel A
Hum Mol Genet; 1997 Sep; 6(9):1549-58. PubMed ID: 9285793
[TBL] [Abstract][Full Text] [Related]
19. Molecular diagnosis of synovial sarcoma: RT-PCR detection of SYT-SSX1/2 fusion transcripts in paraffin-embedded tissue.
Tvrdík D; Povýsil C; Svatosová J; Dundr P
Med Sci Monit; 2005 Mar; 11(3):MT1-7. PubMed ID: 15735574
[TBL] [Abstract][Full Text] [Related]
20. The SYT-SSX1 variant of synovial sarcoma is associated with a high rate of tumor cell proliferation and poor clinical outcome.
Nilsson G; Skytting B; Xie Y; Brodin B; Perfekt R; Mandahl N; Lundeberg J; Uhlén M; Larsson O
Cancer Res; 1999 Jul; 59(13):3180-4. PubMed ID: 10397263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]